Medtronic Announces U.S. Launch of Integrated Health Solutions with University Hospitals Agreement Medical Device Investing
Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2016 Financial Results Biotech Investing
Signal Genetics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement Biotech Investing
Hamilton Thorne Reports 18% Sales Increase for the Quarter Ended September 30, 2016 Medical Device Investing
DILON Diagnostics and GE Healthcare announce the FDA clearance of the Discovery NM 750b biopsy accessory Medical Device Investing
Johnson & Johnson Confirms Discussions with Actelion Regarding Potential Transaction Biotech Investing
